The pharmaceutical industry has low drug prices, so if the recovery rate is more than 20%, there is no margin left

Based on the results of the clinical re-evaluation of the anti-inflammatory enzyme drugs Streptokinase and Streptodornase, the NHIS and pharmaceutical companies, which have started negotiations to recover their salaries, are reportedly showing differences in their positions over the recovery rate. While the NHIS requires more than 20% of the recovery rate, pharmaceutical companies say they can never agree on more than 20%. The return rate of 20% is the rate agreed upon in the negotiation for the return of the brain function improvement drug Choline alfoscerate.

According to t